LipoProtein lipase Polyclonal Antibody-BS65851

LipoProtein lipase Polyclonal Antibody

Sizes: 50µl, 100µl

Catalogue Numbers: BS65851-50, BS65851-100

Product: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Swiss-Prot: P06858

Host: Rabbit

Reactivity: Human, Mouse, Rat, Pig, Cow, Rabbit, Sheep,Guinea Pig,

Applications: WB

All Applications: WB=1:500-2000

Background: Lipoprotein lipase (LPL) is the central enzyme in plasma triglyceride hydrolysis and is secreted by macrophages in the subendothelial space. Evidence has been provided that LPL produced by macrophages in the vessel wall exerts proatherogenic effects. The atherogenic effects of LPL have been mainly attributed to its ability to favor lipid accumulation within macrophages present in the atherosclerotic lesion. Recently, it has also been shown that LPL promote the development of atherosclerosis through facilitation of monocyte adhesion to endothelial cells, stimulation of tumor necrosis factor alpha (TNF ) secretion and induction of vascular smooth muscle cell proliferation.

Purification and Purity: affinity purified by Protein A

Storage and Stability: Store at 4°C short term. Aliquot and store at -24°C long term. Avoid freeze-thaw cycles.

Specificity: Lipoprotein lipase Polyclonal Antibody detects endogenous levels of Lipoprotein lipase protein.

Bioworld Molecular Weight: ~55kDa

Note: For research use only, not for use in diagnostic procedure.

Extra Notes: Primary: Anti-Lipoprotein lipase at 1/300 dilution

Alternative Name: Lipoprotein lipase; LIPD; LIPL_HUMAN; LPL; LPL protein; EC 3.1.1; EC 3.1.1.34; HDLCQ11; LPL; LPL protein; MGC137861.

Immunogen: KLH conjugated synthetic peptide derived from human LPL:401-475/475

Conjugate: Unconjugated

Modification: Unmodified